Rutgers-UMDNJ Researchers Test Potentially Lifesaving Tool for Detecting …
Rutgers-UMDNJ Researchers Test Potentially Lifesaving Tool for Detecting … Diagnosing schizophrenia can be difficult as its symptoms often resemble those of other diseases and conditions, including bipolar illness and severe depression or several neurological disorders. Mental health professionals currently rely on a series … Read more on News from Rutgers Is depression really contagious? That's the word from scientists at Notre Dame University in the United States, who conducted a test on a group of college students suffering from a mild form of depression and anxiety. Researchers observed a group of 108 first year college students … Read more on NEWS.com.au Read more... ...
Mental Illness: Comparing Different Critical Illness Insurance Quotes
by chuck.taylor Every day, thousands of people receive news that they have been diagnosed with a critical illness. For many, the onset of such a scenario can quickly lead to bankruptcy. This is because the treatment costs involved for most critical illnesses are astronomical. The expense of drugs, hospital stays, lab fees and doctors consultations can drain all the savings a person has. Even with medical cover, there is a limit and once it has been passed, cash must be paid. To plan for the unforeseen, it is advisable to request a critical illness insurance quote. Read more... ...
Bipolar-I Guess Everyone Is Gonna Be Gone
Bipolar-I Guess Everyone is Gonna Be Gone – if you would like a good laugh.please see my comedy channel…i need subs lol http://www.youtube.com/user/schizophrenickenny?feature=mhee. Antidepressant Use Okay in Rapid-Cycling Bipolar Disorder? – Medscape A randomized, controlled trial of adults with bipolar II disorder showed that after initial stabilization on the selective serotonin reuptake inhibitor fluoxetine, there were no significant differences in depressive relapse or treatment-emergent mood … Read more on Medscape Read more... ...
IDEXX Laboratories' CEO Discusses Q4 2012 Results – Earnings Call Transcript
IDEXX Laboratories' CEO Discusses Q4 2012 Results – Earnings Call Transcript Also in Q4 and for the year, roughly 80% of ProCyte were sold to Catalyst customers with approximately 60% of that subset being to temporaneous purchase of both instruments, evidence of the important role that the dual plays in enabling real-time care … Read more on Seeking Alpha A Combination Leukemia Can't Take The dual therapy produced only minor side effects in the study. "If you notice … The trial was conducted at The University of Texas MD Anderson Cancer Center and led by Jan Burger, MD, PhD, associate professor in MD Anderson's Department of Leukemia … Read more on dailyRx Read more... ...